CHI3L1 and invasive ductal breast carcinoma: Patients with YKL-40-positive tumors, higher YKL-40 serum concentrations, larger tumor size, invasive ductal carcinoma, TNM stage III, or positive lymph node metastasis had a higher risk for shorter survival time.